Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Fosun Forms JV with BioNTech to Manufacture COVID-19 Vaccine
Shanghai Fosun Pharma (SHA: 600196; HK: 02196) will form a JV with its German partner BioNTech to manufacture COVID-19 vaccine in China. In March, Fosun announced it acquired
The news came from a report in Caixin that, so far, Fosun has not confirmed. No details about time lines or financial specifics were included in the unofficial article that quoted sources who were familiar with the agreement.
In
See our other articles on Fosun and BioNTech.
Disclosure: none.
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China